Doctors told to ration Covid-19 treatment hope remdesivir as NHS ALREADY ‘faces shortages’

Remdesivir, an anti-viral drug first made to try and treat Ebola, has been used experimentally on Covid-19 patients since the outbreak’s early days. It is approved for use by doctors in the UK and US based on early data suggesting it might be helpful, but scientific evidence has been mixed.  There are claims of miraculous … Read more

Arthritis drug combined with remdesivir shortens hospital stays for COVID-19 patients

A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases.  The result have not yet been … Read more

Federal study will test combination of remdesivir and multiple sclerosis in coronavirus patients 

Remdesivir will be combined with a multiple sclerosis drug in next phase of federal tests in hopes the combination will fight deadly inflammation in coronavirus patients Remdesivir has already been approved for emergency use authorization in severe coronavirus patients  Now federal researchers will compared remdesivir and a placebo to remdesivir and beta interferon The drug is approved … Read more

Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir

Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir  The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more

Gilead says it has ramped up production of remdesivir by 50-fold

Gilead Sciences Inc says it has ramped up production of its antiviral remdesivir and expects to produce millions of vials soon enough. The California-based pharmaceutical company announced in a statement on Thursday that it has increased supply by more than 50-fold since January. Officials say they expect to meet ‘real-time global demand’ beginning in October and … Read more

Dr Fauci says US should share remdesivir with the world

America’s top infectious disease expert Dr Anthony Fauci today demanded that Donald Trump share coronavirus wonder drug remdesivir with the world after the US bought up most of the globe’s supply. Dr Fauci, director of the National Institute of Allergy and Infectious Diseases, says he is in favour of an ‘equitable type of distribution’ of … Read more

Fears for UK coronavirus patients as the US buys almost the ENTIRE world stock of remdesivir

The US has bought almost the entire global supply of one of only two drugs proven to be effective against coronavirus.         The drug, made by American pharmaceutical firm Gilead, was initially developed as a failed Ebola treatment but studies have now shown it speeds up recovery from coronavirus. However, patients in the UK and Europe … Read more

US buys nearly all of the global supply of Gilead’s remdesivir

The US government has bought up virtually the entire global supply of remdesivir, the only drug approved in the nation to treat coronavirus, the Department of Health and Human Services (HHS) announced Monday.  That means that any other country will be hard-pressed to get access to the potentially life-saving antiviral medication.  Gilead Sciences, which makes … Read more

The US government’s supply of the remdesivir – will run out at the end of the month

US government’s supply of remdesivir – the only drug shown to work against coronavirus – will run out at the end of the month Redmesivir, made by California-based Gilead Sciences, is the only drug that’s been shown to help shorten the recovery time for coronavirus patients  The US government’s supply is running out and it … Read more

Coronavirus: Remdesivir users 65% more likely to improve

Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more